OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic monitoring of plasma clozapine andN-desmethylclozapine (norclozapine): practical considerations
Robert J. Flanagan, Siobhan Gee, Sarah L. Belsey, et al.
BJPsych Advances (2023) Vol. 29, Iss. 2, pp. 92-102
Open Access | Times Cited: 12

Showing 12 citing articles:

Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition
Georgios Schoretsanitis, A. Elif Anıl Yağcıoğlu, Can‐Jun Ruan, et al.
Schizophrenia Research (2023) Vol. 268, pp. 302-307
Closed Access | Times Cited: 18

Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
Can‐Jun Ruan, I. Cánovas Olmos, Carina Ricciardi, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 15

The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
Anna Mach, Anna Wnorowska, Marcin Siwek, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

Clozapine Dosage in Treatment-Refractory Schizophrenia
Robert J. Flanagan, Stephen John Obee, Alice Hyun Min Kim, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access

Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophrenia
Djenifer B. Kappel, Elliott Rees, Eilidh Fenner, et al.
European Neuropsychopharmacology (2024) Vol. 80, pp. 47-54
Open Access | Times Cited: 3

The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients
Merve Demirbügen Öz, F. Özdemir, Kenan Can Tok, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 5, pp. 319-327
Closed Access | Times Cited: 3

Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics
Orwa Albitar, Sabariah Noor Harun, Siti Maisharah Sheikh Ghadzi
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 571-581
Closed Access

Supporting safe use of clozapine
Tolu Aigbekaen, Caroline Parker
Prescriber (2024) Vol. 35, Iss. 6, pp. 5-12
Closed Access

Mediation and longitudinal analysis to interpret the association between clozapine pharmacokinetics, pharmacogenomics, and absolute neutrophil count
Siobhan K. Lock, Sophie E. Legge, Djenifer B. Kappel, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Rhyme or reason in therapeutics
John Cookson, Jonathan Pimm
BJPsych Advances (2023) Vol. 29, Iss. 2, pp. 74-75
Open Access

Rare Variants in Pharmacogenes Influence Clozapine Metabolism in Individuals with Schizophrenia
Djenifer B. Kappel, Elliott Rees, Eilidh Fenner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Using pharmacogenetic analysis in clinical management with clozapine
Nilema Nasrine, Chloe Stevens, Hoi‐Ying Tam, et al.
Progress in Neurology and Psychiatry (2023) Vol. 27, Iss. 4, pp. 10-14
Open Access

Page 1

Scroll to top